Announcements Trials

Browse Landscape

Phase

Status

Completed 42 Unknown 10 Terminated 9 Recruiting 9 Withdrawn 2 Not yet recruiting 2 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 29 Magnetic Resonance Spectroscopy 18 Biopsy 16 Cyclophosphamide 15 Nivolumab 10 Paclitaxel 9 Vincristine 8 Cisplatin 8 venetoclax 7 Prednisone 7 Gemcitabine 7 Doxorubicin 7 Bevacizumab 7 Azacitidine 7 pembrolizumab 6 Radiotherapy 6 Fluorouracil 6 Etoposide 6 Drug Therapy 6 Docetaxel 6 Rituximab 5 Radiosurgery 5 Oxaliplatin 5 Irinotecan 5 Injections 5 Everolimus 5 Capecitabine 5 fludarabine phosphate 4 Taxes 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Interventional × Hydroxyurea × Clear all

NCT06955169 2026-05-22

MOMENTUM-1

RTOG Foundation, Inc.

Phase 2 Suspended

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡